Skip to main content
Download PDF

Correction to: Massive parallel sequencing in individuals with multiple primary tumours reveals the benefit of re-analysis

Hereditary Cancer in Clinical Practice volume 19, Article number: 47 (2021) Cite this article

The Original Article was published on 28 October 2021

Correction to: Hered Cancer Clin Pract 19, 46 (2021)

https://doi.org/10.1186/s13053-021-00203-z

Following publication of the original article [1], it was identified that in the author panel, the given names and family names were erroneously transposed. The correct names are as follows:

Karin (given name) Wallander (family name)

Håkan (given name) Thonberg (family name)

Daniel (given name) Nilsson (family name)

Emma (given name) Tham (family name)

Further to this, during production, corrections to the order of the references were mistakenly not implemented. The publishers apologize for this error and the references have been corrected.

In the Results section of the article, second paragraph, 14 cm should be changed to 14 mm. The sentence should read as follows: “She also had a malignant melanoma of 1.4 mm at the age of 33.

The original article [1] has been corrected.

Reference

  1. Wallander K, Thornberg H, Nilsson D, et al. Massive parallel sequencing in individuals with multiple primary tumours reveals the benefit of re-analysis. Hered Cancer Clin Pract. 2021;19:46. https://doi.org/10.1186/s13053-021-00203-z.

    Article  Google Scholar 

Download references

Author information

Author notes

  1. Daniel Nilsson and Emma Tham contributed equally to this work.

Authors and Affiliations

  1. Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden

    Karin Wallander, Håkan Thonberg, Daniel Nilsson & Emma Tham

  2. Department of Clinical Genetics, Karolinska University Hospital, Stockholm, Sweden

    Karin Wallander, Håkan Thonberg, Daniel Nilsson & Emma Tham

Authors
  1. Karin Wallander
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Håkan Thonberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Daniel Nilsson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Emma Tham
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Karin Wallander.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wallander, K., Thonberg, H., Nilsson, D. et al. Correction to: Massive parallel sequencing in individuals with multiple primary tumours reveals the benefit of re-analysis. Hered Cancer Clin Pract 19, 47 (2021). https://doi.org/10.1186/s13053-021-00204-y

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s13053-021-00204-y

Hereditary Cancer in Clinical Practice

ISSN: 1897-4287